Breast/Chestwall/S'Clav Planning Flashcards

1
Q

Why multiple fields? (3F)

A

Third field = SCF nodal irradiation
Indicated when:
4+ lymph nodes positive*
25%+ lymph nodes positive*
Apical node positive
Recommended when:
1 – 3 lymph nodes positive

*out of excised axillary nodes
NB: Surgeons do not access supraclavicular site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Why multiple fields? (4F? 5F?)

A

A PA field may be used to increase dose to axilla
An electron field may be used to treat internal mammary chain nodes

slide 12

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

LN levels

A

I - infraclavicular nodes, supraclavicular nodes, apical nodes
II - central nodes
III - lateral nodes

+ IMC, subscapular nodes, pectoral nodes, subareolar plexus

Level 1 axilla overlap with chestwall, usually not included in sclav field as tend to be covered in chestwall field

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Field Junctioning - what is it? positioning importance? types of junctions?

A

Means matching of adjacent treatment fields
Multiple isocentres or monoisocentric
Requires accurate planning and treatment setup techniques
Need to be very accurate in patient positioning, because junctions could result in hot/cold spots

Patient stability and setup accuracy are extremely important when treating with junctions to avoid areas of:
Overdose = risk increased side-effects
Under-dose = risk treatment failure

Types of junctions in breast/chestwall RT
Photon – photon
Photon – electron
[Electron – electron]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

If field junction is matched at skin

A

Beams diverges at depth, overlap, then create a high dose region in the shape of a spike where beams overlap underneath skin
Unacceptable

  • Solution use half-beam blocking (non-divergence at central axis) OR add gap between fields

Slide 17

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

If fields have 1cm gap

A

Note, beams still diverging, but have 1cm gap between beam edges, region of overlap happens far below the skin…

Looks better, but need to be careful of ‘cold spots’ now
95% separated? Tumour coverage?
Have to be careful of junctions, role: don’t junction over areas of confirmed disease
Junction only when disease is NOT superficial

slide 18

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Field Junctioning for Breast/Chestwall

A

Several options: Geometric matching and/or half-beam block

Beams are angled to match along a straight edge
Using gantry, collimator, couch rotation (or combination)
Half-beam block shields half of the beam
Produces non-divergent beam edge
Stationary block or asymmetric jaws create block

Multiple isocentres: setup error?

Examples on slide 19

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Field Junction w/ multiple isocentres

A

Might see if breast/chest wall field is required to be longer than 20cm

Multiple isos:
High chance of setup error
Patient movement bc longer tmt and shifting couch
Hot/cold spots along junction
Matching using couch rotation

SCF field:
Asymmetric
Half-beam block along INF beam edge

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Mono-isocentric technique

A

Single iso at junction
Separate dpts for SCF and tangents

Half-beam block
One jaw closes to central axis, creates non-divergent beam edge
No couch movement needed to match planes

Advantages:
Simpler and faster patient setup
Image verification needed for one point only

Disadvantage:
Limited beam length to half of maximum field size

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Dose point placement SCF field
(mono-isocentric)

A

Placed at effective centre of the field
At prescribed depth (given by RO) and in tissue as per ICRU guidelines (density 1.0g/cm3)
Above bone, not in density interface

May be prescribed to a specific depth or to cover volumes (SCF/axilla nodes)
Depends on department and RO preference

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Dose point placement tangents
(mono-isocentric)

A

Placed at effective centre of the field/PTV
Where the isocentre would be for a symmetric technique
In tissue as per ICRU
Move closer to junction if dose to SUP part of field is not adequate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Patient Positioning

A

Similar to tangents but some specific instructions

Breast board
Patient flat as possible to achieve a flat sternum – minimises dose to lung from SCF field
Elevating breast board may be considered for larger patients if breast settles too superiorly
Must fit through CT scanner

Head RO preference:
Head straight (chin extended) to avoid SCF field or
Turned to contra-lateral side

Arm position
Both arms up or one arm up (affected side)
Must ensure patient fits through CT scanner
Wide SCF/axilla field: contra-lateral arm down
Adjust arm position to reduce axillary folds

Other considerations:
Kneefix
Ensure patient is straight, level, stable and that position will be reproducible
Planning junctioning/technique cannot use collimator angle as SUP border of field (junction) must be straight and vertical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

SCF Field borders

A

Half-beam block to INF border using asymmetric jaws

Field borders depend of position of involved or at risk lymph nodes
SUP B: Include all SCF (indentation above clavicle), approximately 5 cm SUP to SN
INF B: Isocentre/junction; avoid placing over involved nodal groups; at angle of Louis to cover the clavicle; just SUP to palpable breast tissue; or at a point > 2 cm SUP to original mass
MED B: Midline (unless nodal groups extend over ML); exclude spinal cord [and thyroid gland as per RTOG guidelines]
LAT B: To include 2-3 cm humeral head, wider if axilla involved

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

SCF Field Shielding

A

Shielding: larynx [if indicated], humerus

Field length <10 cm, minimise amount of lung in field (50gy to whole field, so need to be careful with amount of lung in field)

Note other OARs, what are they?
- cord

Possible gantry angle to avoid larynx/cord (AP vs. APO)
If APO (e.g. 5°), medial beam edge is vertical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

PA axilla field rationale

A

Scenario 1:
Increase dose to mid-axilla (prescribed dose = 50 Gy) in patients who have not had Level III lymph nodes dissected.

Scenario 2: Large patient separation when dose from SCF alone is insufficient

Increase dose to mid-axilla to 45-50gy
PA field parallel opposed to SCF field, medial border reduced, need to be at 100FSD when using varian (risk of collision)
Separate dose point

AP field won’t achieve this (50Gy to mpd/midaxilla) without getting too much ANT dose.
Need to ‘boost’ from PA
PA field, dose pt. added at mid-plane, but dose contribution small to ‘top up’ to midplane point (i.e. 0.42Gy/#)
Disadv – hot anteriorly, but getting 50gy to where we need to

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

IMC RT

A

IMC location: parasternal region in the inter-costal spaces
Nodes at approx. 4 cm depth, 2 - 3 cm either side of ML

RT technique
Anterior electron field, heart sparing, consider photon/electron junction
Medial border of tangents widened across ML, but dose to heart and lung increases

17
Q

IMC w/ direct electron field

A

Junctions to match:
- SUP border electrons with INF border SCF field
- MED border electrons with tangent field
Hot/cold spots need to be determined

18
Q

IMC with widened tangents – LT sided

A

Wide tangent includes IMC
Larger volume of lung and heart in field
OAR doses increased

diagram slide 20

19
Q

IMC with widened tangents – RT sided

A

Wide tangent includes IMC
Larger volume of lung and heart in field
OAR doses increased